Abbas Deesawala

Abbas Deesawala currently serves as the Global Head of Business Development & Licensing and Director of Strategy at Cooper Pharma since April 2023, where responsibilities include leading strategic initiatives in M&A, new market entry, and business development across multiple geographies. Prior experience includes roles such as Assistant Director for Commercial at Lotus Pharmaceutical, focusing on SEA markets, and various positions at Cooper Pharma, Alvogen, and Cipla, offering strong expertise in portfolio management, strategic development, and market expansion in the pharmaceutical sector. Educational background includes a Master of Science in Biotechnology from the University of Warwick and ongoing finance studies at Loyola Institute of Business Administration, complemented by a Bachelor of Technology in Biotechnology from Vellore Institute of Technology.